Chile vs Russian Federation: Previously treated cases tested for RR-/MDR-TB
Chile
99.0%
in 2024
Russian Federation
98.0%
in 2024
Chile rank
56th
Russian Federation rank
58th
Previously treated cases tested for RR-/MDR-TB over time
- Chile
- Russian Federation
How they compare
Chile currently reports 99.0% against 98.0% in Russian Federation, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2007 it was Chile ahead.
Chile ranks 56th and Russian Federation ranks 58th of 180 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Russian Federation in 1.
Head to head by decade
| Decade | Chile | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.7% | 10.9% | 76.7% | Chile |
| 2010s | 77.7% | 47.2% | 30.5% | Chile |
| 2020s | 85.6% | 95.8% | 10.2% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Chile or Russian Federation?
- Chile, at 99.0% against 98.0% in Russian Federation as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Chile and Russian Federation?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Russian Federation?
- 18 years are reported by both, from 2007 to 2024.
- How do Chile and Russian Federation rank globally for previously treated cases tested for rr-/mdr-tb?
- Chile ranks 56th and Russian Federation ranks 58th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.